GTS Securities’s Alnylam Pharmaceuticals ALNY Stock Holding History

GTS Securities’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$348K	Buy	1,052 +527	+100%	+$179K	0.01%	1007
2025 Q4	$209K	Buy	+525	New	+$232K	0.01%	1260
2025 Q3	–	Sell	-747	Closed	-$244K	–	1414
2025 Q2	$244K	Buy	+747	New	+$207K	0.01%	1017
2025 Q1	–	Sell	-1,163	Closed	-$274K	–	1225
2024 Q4	$274K	Sell	1,163 -7,040	-86%	-$1.85M	0.01%	940
2024 Q3	$2.26M	Buy	8,203 +7,107	+648%	+$1.85M	0.05%	1490
2024 Q2	$266K	Buy	+1,096	New	+$173K	0.01%	3227
2024 Q1	–	Sell	-1,966	Closed	-$328K	–	3808
2023 Q4	$376K	Buy	+1,966	New	+$335K	0.01%	3019
2023 Q3	–	Hold	0	–	–	–	3907

Other funds holding ALNY

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return